ADDICTION
Clinical trials for ADDICTION explained in plain language.
Never miss a new study
Get alerted when new ADDICTION trials appear
Sign up with your email to follow new studies for ADDICTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cough medicine combo help fight opioid addiction?
Disease control CompletedThis early-phase study tested whether adding a medication called AUVELITY (a mix of dextromethorphan and bupropion) to standard buprenorphine/naloxone treatment is safe for people with opioid use disorder. 18 adults on stable buprenorphine treatment took part. Researchers monitor…
Matched conditions: ADDICTION
Phase: PHASE1, PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 26, 2026 11:13 UTC
-
Protein shakes may curb addiction cravings, small study suggests
Symptom relief CompletedThis pilot study tested whether adding protein supplements to the diet could lower cravings in people hospitalized for addiction. 28 participants spent one week with protein supplements and one week without, rating their cravings daily. The goal was to see if protein could ease t…
Matched conditions: ADDICTION
Phase: NA • Sponsor: Centre Hospitalier de PAU • Aim: Symptom relief
Last updated May 26, 2026 11:18 UTC
-
Can a common supplement curb alcohol cravings and PTSD symptoms?
Symptom relief CompletedThis study tested whether N-acetylcysteine (NAC), a supplement, can help people who struggle with both alcohol use disorder and PTSD. 182 adults took either NAC or a placebo for a period, and researchers measured changes in drinking habits, cravings, and PTSD symptoms. The goal w…
Matched conditions: ADDICTION
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated May 26, 2026 11:18 UTC
-
Brain zaps curb smoking cravings in stubborn cases
Symptom relief CompletedThis study tested whether low-frequency magnetic brain stimulation (rTMS) could reduce tobacco cravings in heavy smokers who had already failed multiple quit attempts. 39 adults who were highly dependent on nicotine and wanted to quit received either real or fake rTMS over two we…
Matched conditions: ADDICTION
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Breathwork boosts emotional wellness in addiction recovery
Symptom relief CompletedThis study looked at whether a program called SKY Recovery, which teaches breathing and meditation, can help people recovering from substance use disorder. About 100 people in a residential treatment center took part. The program included a 5-day workshop and weekly follow-ups. R…
Matched conditions: ADDICTION
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Could a single pill before kidney stone surgery cut opioid use?
Symptom relief CompletedThis study tested whether giving a single dose of pregabalin (a nerve pain medication) about an hour before kidney stone surgery could reduce pain and the need for opioid painkillers afterward. 118 adults having ureteroscopy with a ureteral stent were randomly assigned to receive…
Matched conditions: ADDICTION
Phase: PHASE2, PHASE3 • Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated May 18, 2026 12:12 UTC
-
Breathwork shows promise for addiction recovery in small pilot study
Symptom relief CompletedThis study tested a breathing technique called Holotropic Breathwork to help people recover from addiction. 25 adults in residential treatment or living in the community took part. The goal was to see if the practice is safe, acceptable, and might reduce substance use and improve…
Matched conditions: ADDICTION
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC
-
CBD shows promise for opioid addiction and pain in small study
Symptom relief CompletedThis early-stage study tested whether cannabidiol (CBD) is safe and helpful for people who are being treated for opioid addiction and also have long-term pain. Seven adults on methadone or buprenorphine received CBD or a placebo in a controlled setting. Researchers measured sedat…
Matched conditions: ADDICTION
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Massive screening effort seeks volunteers for addiction research
Knowledge-focused CompletedThis study screened nearly 7,000 volunteers to find people eligible for future research on drug addiction and its effects on the brain and body. Participants completed phone and in-person interviews, medical exams, and lab tests. No treatment or clinical care was provided.
Matched conditions: ADDICTION
Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated May 26, 2026 11:20 UTC
-
AI uncovers hidden subtypes of addiction in new study
Knowledge-focused CompletedThis study used artificial intelligence to analyze personality and behavior data from 155 adults in residential treatment for substance use disorders. The goal was to find hidden patterns that could help doctors tailor treatments to individual patients. No treatment was given; th…
Matched conditions: ADDICTION
Sponsor: Lauro Gutiérrez Castro • Aim: Knowledge-focused
Last updated May 26, 2026 11:16 UTC
-
Can a cultural training program help communities respond to mental health crises?
Knowledge-focused CompletedThis study tested a training program called First Face, designed to help community members recognize and respond to mental health crises. 92 staff from the Healing Lodge of the Seven Nations took surveys before, right after, and 3 months after training. The goal was to see if the…
Matched conditions: ADDICTION
Phase: NA • Sponsor: Cambridge Health Alliance • Aim: Knowledge-focused
Last updated May 26, 2026 11:16 UTC
-
Prison TB study aims to find better prevention for vulnerable inmates
Knowledge-focused CompletedThis study looked at how to best prevent tuberculosis (TB) in Malaysian prisons, focusing on inmates with and without opioid dependence. Researchers compared two TB prevention treatments: a standard daily medicine for 40 weeks versus a shorter weekly combination for 12 weeks. The…
Matched conditions: ADDICTION
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 20, 2026 12:00 UTC